BridgeMD
New treatment option for Isoflurane
Official title Impact of Isoflurane and Sevoflurane on Oxidative Stress in Patients Undergoing Laparoscopic Cholecystectomy
ClinicalTrials.gov ID: NCT07152912
What this study is testing
What is Isoflurane?
Isoflurane is an investigational medicine, given as an inhaled treatment, being studied as a potential treatment for isoflurane.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The primary aim of this work is to assess the impact of exposure to isoflurane or sevoflurane as an inhalation anesthetic on the oxidative stress and inflammatory conditions in patients undergoing elective moderate invasive surgery (laparoscopic cholecystectomy).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 60
You may be able to join if
- Age from 20 to 60 years.
- Both sexes.
- American Society of Anesthesiologists (ASA) Physical Status I-II.
- Undergoing elective laparoscopic cholecystectomy under general anesthesia.
You likely can't join if
- Refusal of participation in the study by patients.
- Diabetes (type I or II), endocrine system, and immune system diseases.
- Chronic infection and sepsis.
- Cardiac condition as classified bythe New York Heart Association (NYHA) \> class II.
- Hepatic disease: INR \> 1.5, and/or albumin \< 2.5 g/dL.
- Renal disease: glomerular filtration rate (GFR) \< 85 ml/min.
See the full eligibility criteria
- Age from 20 to 60 years.
- Both sexes.
- American Society of Anesthesiologists (ASA) Physical Status I-II.
- Undergoing elective laparoscopic cholecystectomy under general anesthesia.
- Refusal of participation in the study by patients.
- Diabetes (type I or II), endocrine system, and immune system diseases.
- Chronic infection and sepsis.
- Cardiac condition as classified bythe New York Heart Association (NYHA) \> class II.
- Hepatic disease: INR \> 1.5, and/or albumin \< 2.5 g/dL.
- Renal disease: glomerular filtration rate (GFR) \< 85 ml/min.
- Mental and neurological disorders.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.